Reversible pH-switchable NIR-II nano-photosensitizer for precise imaging and photodynamic therapy of tumors.

Yun Chai, Ye Sun, Zhijia Sheng, Yanyan Zhu, Tianyou Du, Bingjian Zhu, Hui Yu, Bin Dong, Yi Liu, Hai-Yan Wang
{"title":"Reversible pH-switchable NIR-II nano-photosensitizer for precise imaging and photodynamic therapy of tumors.","authors":"Yun Chai, Ye Sun, Zhijia Sheng, Yanyan Zhu, Tianyou Du, Bingjian Zhu, Hui Yu, Bin Dong, Yi Liu, Hai-Yan Wang","doi":"10.1016/j.actbio.2024.09.001","DOIUrl":null,"url":null,"abstract":"<p><p>Photodynamic therapy (PDT) has attracted widespread attention from researchers as an emerging cancer treatment method. There have been many reports on various types of NIR-II photosensitizers for imaging and treatment of tumor sites. However, there are few reports on the development of NIR-II organic small molecule photosensitizers that have intelligent response to the tumor microenvironment, precise imaging, real-time treatment, and high biocompatibility. In this work, we developed a series of NIR-II photosensitizers (RBTs) with near-infrared excitation, good photostability, and large Stokes shift. Among them, RBT-Br exhibited higher reactive oxygen species (ROS) generation efficiency due to the introduction of halogen heavy atoms to enhance intersystem crossing (ISC). It is noteworthy that RBT-Br can generate singlet oxygen (<sup>1</sup>O<sub>2</sub>) and superoxide anion radicals (<sup>•</sup>O<sub>2</sub><sup>-</sup>) simultaneously under 730 nm laser. Subsequently, we used molecular engineering technology to construct three pH-responsive NIR-II photosensitizers (RBT-pHs) by utilizing the closure of the lactam ring, among which RBT-pH-1 (pK<sub>a</sub> = 6.78) is able to be directionally activated under the stimulation of tumor micro-acid environment, with its fluorescence emission window reaching 933 nm. Subsequently, RBT-pH-1 NPs encapsulated in DSPE-mPEG<sub>5k</sub> were applied for PDT treatment of mouse tumors. The results showed that RBT-pH-1 NPs were activated by the acidic tumor microenvironment and generated ROS under laser excitation, exhibiting precise tumor imaging and significant tumor growth inhibition. We look forward to these multifunctional NIR-II organic small molecule photosensitizers providing a more efficient approach for clinical treatment of tumors. STATEMENT OF SIGNIFICANCE: A reversible pH-switchable NIR-II nano-photosensitizer RBT-pH-1 NPs (pK<sub>a</sub> = 6.76) is developed for precise imaging and PDT therapy of mouse tumors, which can be effectively used for targeted enrichment and activation of tumor micro-acid environments. The results show that this NIR-II photosensitizer generates ROS through tumor micro-acid environment stimulation and laser triggering, showing precise tumor imaging guidance and significant tumor growth inhibition.</p>","PeriodicalId":93848,"journal":{"name":"Acta biomaterialia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta biomaterialia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.actbio.2024.09.001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Photodynamic therapy (PDT) has attracted widespread attention from researchers as an emerging cancer treatment method. There have been many reports on various types of NIR-II photosensitizers for imaging and treatment of tumor sites. However, there are few reports on the development of NIR-II organic small molecule photosensitizers that have intelligent response to the tumor microenvironment, precise imaging, real-time treatment, and high biocompatibility. In this work, we developed a series of NIR-II photosensitizers (RBTs) with near-infrared excitation, good photostability, and large Stokes shift. Among them, RBT-Br exhibited higher reactive oxygen species (ROS) generation efficiency due to the introduction of halogen heavy atoms to enhance intersystem crossing (ISC). It is noteworthy that RBT-Br can generate singlet oxygen (1O2) and superoxide anion radicals (O2-) simultaneously under 730 nm laser. Subsequently, we used molecular engineering technology to construct three pH-responsive NIR-II photosensitizers (RBT-pHs) by utilizing the closure of the lactam ring, among which RBT-pH-1 (pKa = 6.78) is able to be directionally activated under the stimulation of tumor micro-acid environment, with its fluorescence emission window reaching 933 nm. Subsequently, RBT-pH-1 NPs encapsulated in DSPE-mPEG5k were applied for PDT treatment of mouse tumors. The results showed that RBT-pH-1 NPs were activated by the acidic tumor microenvironment and generated ROS under laser excitation, exhibiting precise tumor imaging and significant tumor growth inhibition. We look forward to these multifunctional NIR-II organic small molecule photosensitizers providing a more efficient approach for clinical treatment of tumors. STATEMENT OF SIGNIFICANCE: A reversible pH-switchable NIR-II nano-photosensitizer RBT-pH-1 NPs (pKa = 6.76) is developed for precise imaging and PDT therapy of mouse tumors, which can be effectively used for targeted enrichment and activation of tumor micro-acid environments. The results show that this NIR-II photosensitizer generates ROS through tumor micro-acid environment stimulation and laser triggering, showing precise tumor imaging guidance and significant tumor growth inhibition.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于肿瘤精确成像和光动力治疗的可逆 pH 开关 NIR-II 纳米光敏剂。
光动力疗法(PDT)作为一种新兴的癌症治疗方法引起了研究人员的广泛关注。关于用于肿瘤部位成像和治疗的各类近红外-II 光敏剂的报道很多。然而,关于开发对肿瘤微环境具有智能响应、精确成像、实时治疗和高生物相容性的 NIR-II 有机小分子光敏剂的报道却很少。在这项工作中,我们开发了一系列具有近红外激发、良好光稳定性和较大斯托克斯位移的 NIR-II 光敏剂(RBTs)。其中,RBT-Br 具有更高的活性氧(ROS)生成效率,这是由于引入了卤素重原子以增强系统间交叉(ISC)。值得注意的是,RBT-Br 能在 730 纳米激光下同时产生单线态氧(1O2)和超氧阴离子自由基(-O2-)。随后,我们利用分子工程技术,利用内酰胺环的封闭性构建了三种 pH 响应型近红外-II 光敏剂(RBT-pHs),其中 RBT-pH-1(pKa = 6.78)在肿瘤微酸环境的刺激下能够定向激活,其荧光发射窗口达到 933 nm。随后,将封装在 DSPE-mPEG5k 中的 RBT-pH-1 NPs 应用于小鼠肿瘤的 PDT 治疗。结果表明,RBT-pH-1 NPs 被酸性肿瘤微环境激活,并在激光激发下产生 ROS,表现出精确的肿瘤成像和显著的肿瘤生长抑制作用。我们期待这些多功能 NIR-II 有机小分子光敏剂为临床治疗肿瘤提供更有效的方法。意义声明::本研究开发了一种可逆的 pH 开关型 NIR-II 纳米光敏剂 RBT-pH-1 NPs(pKa = 6.76),用于小鼠肿瘤的精确成像和 PDT 治疗,可有效用于肿瘤微酸环境的靶向富集和激活。结果表明,这种 NIR-II 光敏剂通过肿瘤微酸环境刺激和激光触发产生 ROS,显示出精确的肿瘤成像引导和显著的肿瘤生长抑制作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Tuning a Bioengineered Hydrogel for Studying Astrocyte Reactivity in Glioblastoma. Versatile Self-Assembled Near-Infrared SERS Nanoprobes For Multidrug-Resistant Bacterial Infection-Specific Surveillance and Therapy. An Optical System for Cellular Mechanostimulation in 3D Hydrogels. Automated model discovery for textile structures: The unique mechanical signature of warp knitted fabrics. Biopolymer Immune Implants co-loaded with TMZ, R848 and IOX1 for Perioperative Therapy of Glioblastoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1